DE69001342D1 - Heterocyclische derivate mit lipoxygenase hemmender wirkung. - Google Patents

Heterocyclische derivate mit lipoxygenase hemmender wirkung.

Info

Publication number
DE69001342D1
DE69001342D1 DE9090402692T DE69001342T DE69001342D1 DE 69001342 D1 DE69001342 D1 DE 69001342D1 DE 9090402692 T DE9090402692 T DE 9090402692T DE 69001342 T DE69001342 T DE 69001342T DE 69001342 D1 DE69001342 D1 DE 69001342D1
Authority
DE
Germany
Prior art keywords
group
atom
alkatriynyl
alkadiynyl
alkatrienyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE9090402692T
Other languages
English (en)
Other versions
DE69001342T2 (de
Inventor
- Moakuresuto-Tamagawa Ubasawa
- Guriin-Hiru-Kamoshi Kadowaki
Yoshio Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Application granted granted Critical
Publication of DE69001342D1 publication Critical patent/DE69001342D1/de
Publication of DE69001342T2 publication Critical patent/DE69001342T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE9090402692T 1989-09-29 1990-09-28 Heterocyclische derivate mit lipoxygenase hemmender wirkung. Expired - Fee Related DE69001342T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25453089 1989-09-29

Publications (2)

Publication Number Publication Date
DE69001342D1 true DE69001342D1 (de) 1993-05-19
DE69001342T2 DE69001342T2 (de) 1993-07-29

Family

ID=17266325

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9090402692T Expired - Fee Related DE69001342T2 (de) 1989-09-29 1990-09-28 Heterocyclische derivate mit lipoxygenase hemmender wirkung.

Country Status (8)

Country Link
US (1) US5206255A (de)
EP (1) EP0420762B1 (de)
JP (1) JPH03173874A (de)
AT (1) ATE88184T1 (de)
CA (1) CA2026227A1 (de)
DE (1) DE69001342T2 (de)
DK (1) DK0420762T3 (de)
ES (1) ES2054300T3 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
PL319605A1 (en) * 1994-10-12 1997-08-18 Euro Celtique Sa Novel benzoxazoles
US5665737B1 (en) * 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
AU4527896A (en) * 1994-12-13 1996-07-03 Euro-Celtique S.A. Aryl thioxanthines
DE69531555T2 (de) * 1994-12-13 2004-06-17 Euroceltique S.A. Dreifachsubstituierte thioxanthine
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
US20050234394A1 (en) * 2004-03-26 2005-10-20 Rod Ross Dual cylinder vacuum pump for medical aspiration system
MY141272A (en) * 2006-06-29 2010-04-16 Dow Agrosciences Llc High-strength, low-temperature stable herbicidal formulations of fluroxypyr esters
KR100910151B1 (ko) 2007-11-22 2009-07-30 (주)그라쎌 신규한 유기 발광 화합물 및 이를 발광재료로 채용하고있는 전기발광소자
ES2887354T3 (es) * 2009-01-07 2021-12-22 Med Logics Inc Dispositivos para la eliminación de tejido
US9999710B2 (en) 2009-01-07 2018-06-19 Med-Logics, Inc. Tissue removal devices, systems and methods
EP2741607B1 (de) 2011-08-11 2018-10-17 Bayer CropScience Aktiengesellschaft Verwendung und agrochemische zusammensetzung von carbonsäure-dibutylamiden
JP6427169B2 (ja) 2013-04-26 2018-11-21 メッド−ロジックス，インク． 組織除去装置、システム、及び方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574218A (en) * 1969-08-11 1971-04-06 Egyt Gyogyszervegyeszeti Gyar 2-aryl- or aralkyl-substituted benzazole derivatives
GB1491863A (en) * 1973-10-23 1977-11-16 Lilly Industries Ltd 2,5-or 2,6-disubstituted benzoxazoles
DE2711656A1 (de) * 1977-03-17 1978-09-21 Basf Ag Neue pyridin-3-ole
DE2907089A1 (de) * 1979-02-23 1980-09-04 Hoechst Ag Herbizide mittel
US4594425A (en) * 1984-02-09 1986-06-10 American Home Products Corporation Heterocyclic compounds as antiallergic agents
US4675405A (en) * 1984-09-21 1987-06-23 American Home Products Corporation Quinoline compounds as antiallergic and antithrombotic agents
US4732978A (en) * 1985-10-03 1988-03-22 American Home Products Corporation Novel substituted naphthyloxymethyl quinoline derivatives as anti-inflammatory and antiallergy agents
JPS62142168A (ja) * 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
US4904786A (en) * 1986-01-27 1990-02-27 American Home Products Corporation Quinoline compounds as antiallergic and antiinflammatory agents
US4772703A (en) * 1986-01-27 1988-09-20 American Home Products Corporation 2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents
FI91869C (fi) * 1987-03-18 1994-08-25 Tanabe Seiyaku Co Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
EP0318085A3 (de) * 1987-11-25 1990-03-14 Merck Frosst Canada Inc. Heterazoldialkansäure
CA1322005C (en) * 1987-11-25 1993-09-07 Robert N. Young Benzoheterazoles
NZ229761A (en) * 1988-07-12 1991-10-25 Ici Pharma Substituted thiazole derivatives for use as inhibitors of enzyme 5-lipoxygenase; pharmaceutical compositions and preparatory processes

Also Published As

Publication number Publication date
ES2054300T3 (es) 1994-08-01
US5206255A (en) 1993-04-27
DE69001342T2 (de) 1993-07-29
EP0420762A3 (en) 1991-07-31
CA2026227A1 (en) 1991-03-30
DK0420762T3 (da) 1993-08-16
ATE88184T1 (de) 1993-04-15
EP0420762B1 (de) 1993-04-14
JPH03173874A (ja) 1991-07-29
EP0420762A2 (de) 1991-04-03

Similar Documents

Publication Publication Date Title
DE69001342D1 (de) Heterocyclische derivate mit lipoxygenase hemmender wirkung.
YU172490A (sh) Novi 4-benzoil izoksazol derivati
ES2063300T3 (es) Derivado de acido aminobencensulfonico.
IL160874A0 (en) 4-imidazolin-2-one derivatives
ES2104761T3 (es) Derivado de benzotiazol.
KR920009295A (ko) 트리아졸일-또는 이미다졸일메틸알릴 알콜 및 신규 화합물에 의한 식물증식물 보호방법
ZA914749B (en) Microbicides
ATE193204T1 (de) Präparat zur behandlung der drogenabhängigkeit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee